mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal

Emanuela Guerra1, Rossano Lattanzio, Rossana La Sorda

  • 1Unit of Cancer Pathology, CeSI, University G. d'Annunzio Foundation, Chieti, Italy. emanuela.guerra5@gmail.com

Plos One
|December 5, 2012
PubMed

Insights

Congenital tufting enteropathy (CTE) is caused by EPCAM gene mutations. This study generated a mouse model with CTE-like symptoms, confirming EPCAM

Area of Science:

  • Genetics and Molecular Biology
  • Gastroenterology
  • Developmental Biology

Background:

  • Congenital tufting enteropathy (CTE) is a severe inherited diarrheal disease.
  • Loss-of-function mutations in the EPCAM gene are implicated in human CTE.
  • Previous mouse models suggested EPCAM might not be the sole cause due to embryonic lethality.

Purpose of the Study:

  • To clarify the role of EPCAM in CTE.
  • To develop a viable animal model for CTE research and therapeutic development.

Main Methods:

  • Utilized a gene-trapping approach to create EPCAM-null (knockout) mice.
  • Observed and analyzed the phenotype of the resulting knockout mice.
  • Examined intestinal tissue for structural and molecular changes.

Main Results:

  • EPCAM-null mice exhibited symptoms mirroring human CTE, including intestinal tufting, villous atrophy, and diarrhea.
  • These mice died shortly after birth due to hemorrhagic diarrhea.
  • Dysregulation of E-cadherin and beta-catenin was observed in the enteric mucosa.

Conclusions:

  • Loss of EPCAM function is directly causative of CTE.
  • The generated mouse model is suitable for studying CTE pathogenesis and testing therapies.
  • EPCAM is crucial for maintaining intestinal architecture and epithelial cell adhesion.